Items where Author is "Marriott, C.E."
Group by: Item Type | No Grouping
Number of items: 6.
Ferris, W.F., Marriott, C.E., Ali, T., Landy, C., Campbell, S.C. and Macfarlane, W.M. (2011) Tumor suppressor PDCD4 is a major transcript that is upregulated during in vivo pancreatic islet neogenesis and is expressed in both beta-cell and ductal cell lines Pancreas, 40 (1). pp. 61-66. ISSN 0885-3177
Ali, T., Landy, C., Marriott, C.E., Harrison, M. and Macfarlane, W.M. (2010) Imagining beta-cell lipotoxicity Diabetic Medicine, 27 (38). p. 5. ISSN 0742-3071
Persaud, S.J., Arden, C., Bergsten, P., Bone, A.J., Brown, J., Dunmore, S., Harrison, M., Hauge-Evans, A., Kelly, C., King, A., Maffucci, T., Marriott, C.E., McClenaghan, N., Morgan, N.G., Reers, C., Russell, M.A., Turner, M.D., Willoughby, E., Younis, M.Y.G., Zhi, Z.L. and Jones, P.M. (2010) Pseudoislets as primary islet replacements for research: report on a symposium at King's College London Islets, 2 (4). pp. 236-239. ISSN 1938-2014
Ali, T., Landy, C., Marriott, C.E., Harrison, M. and Macfarlane, W.M. (2009) Rosiglitazone down-regulates p38 stress activated kinase and prevents pancreatic beta cells from lipotoxicity-induced dysfunction Diabetic Medicine, 26 (s1). p. 6. ISSN 0742-3071
Aldibbiat, A., Marriott, C.E., Scougall, K.T., Campbell, S.C., Huang, G.C., Macfarlane, W.M. and Shaw, J.A.M. (2008) Inability to process and store proinsulin in transdifferentiated pancreatic acinar cells lacking the regulated secretory pathway Journal of Endocrinology, 196. pp. 33-43. ISSN 0022-0795
Landy, C., Ali, T., Crawford, R., Marriott, C.E., Woollhead, A.M., Harrison, M. and Macfarlane, W.M. (2008) Rosiglitazone modulates multiple signalling pathways in pancreatic beta cells and protects beta cells from the detrimental effects of free fatty acids Diabetes, 57 (Supplement 1A). p. 467. ISSN 0012-1797